Increasing Aptamer Affinity from Millimolar to Nanomolar by Forming a Covalent Adduct for Detecting Acrylamide.

Anal Chem

Department of Chemistry, Waterloo Institute for Nanotechnology, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada.

Published: May 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Being a neurotoxin and carcinogen, acrylamide has been an important target for developing biosensors. DNA aptamers are attractive for making biosensors due to their programmable structure, low cost, and ease of modification. However, DNA aptamers have poor affinities to low-binding epitope target molecules such as acrylamide. In this work, an aptamer for acrylamide was isolated with an apparent of 10.5 mM using a thioflavin T fluorescence assay and 4.7 mM using the fluorescence strand-displacement assay. To improve binding affinity, acrylamide was reacted with xanthydrol to form a covalent adduct, and a new aptamer selected for this adduct achieved a of 20 nM using the strand-displacement assay, representing an improvement of 235,000-fold. Using the strand-displacement biosensor, a limit of detection of 4.2 nM was achieved for the adduct. This work demonstrates a practical route to convert low epitope targets to high-affinity targets for aptamer binding and bioanalytical applications.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.analchem.5c00783DOI Listing

Publication Analysis

Top Keywords

covalent adduct
8
dna aptamers
8
strand-displacement assay
8
acrylamide
5
increasing aptamer
4
aptamer affinity
4
affinity millimolar
4
millimolar nanomolar
4
nanomolar forming
4
forming covalent
4

Similar Publications

Objective: To investigate the effects of carnosine on heart failure and to examine whether this is associated with reduced immunogenicity of oxidatively-generated aldehyde modified proteins.

Background: Heart failure is associated with the accumulation of lipid derived aldehydes that form immunogenic protein adducts. However, the pathological impact of these aldehydes and aldehyde-modified proteins in heart failure has not been assessed.

View Article and Find Full Text PDF

Mollugin reacts with phenol thiol but not produce modification on cysteine discovered by a phenol thiol probe.

Front Cell Dev Biol

August 2025

Department of Pathogen Biology and Biosecurity, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.

Electrophilic compounds from natural products (NPs) and metabolites can covalently modify the cysteines of target proteins to induce biological activities. To facilitate the discovery of novel NPs and metabolites, chemical probes with various thiol groups-mimicking the reactivity of cysteine-have been developed. These probes are designed to react with electrophilic groups of NPs and metabolites in an electrophilic addition mechanism, with the resulting adducts having molecular masses which equal to the sum of the probe and the target compound.

View Article and Find Full Text PDF

A synergistic-available and high-potent New Delhi metallo-β-lactamase-1 (NDM-1) covalent inhibitor by the modification of naturally occurring 3-formyl chromone.

Bioorg Chem

August 2025

School of Chemical Engineering and Technology,Guangdong Engineering Technology Research Center for Platform Chemicals from Marine Biomass and Their Functionalization, Sun Yat-sen University, Zhuhai 519082, PR China.

The discovery of novel NDM-1 inhibitors is one of the currently rocky and urgent tasks to fight superbug crisis. Here, we designed and synthesized three types derivatives of the 3-formyl chromone that is a naturally occurring covalent NDM-1 inhibitor. Further, their sodium bisulfite adducts have been obtained and the inhibitory activities have been explored.

View Article and Find Full Text PDF

Next-generation tetracycline antibiotics are threatened by an emerging resistance mechanism ─ enzymatic inactivation. The relevant enzymes ─ tetracycline destructases (TDases) ─ are structural homologues of class A flavin monooxygenase (FMO) that oxidize tetracycline antibiotics, leading to various inactive degradation products. Small molecule inhibitors of antibiotic-inactivating enzymes are critical clinical therapeutics used to manage bacterial resistance with combination therapy.

View Article and Find Full Text PDF

SARM1 activation promotes axonal degeneration via a two-step phase transition.

Nat Chem Biol

August 2025

Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing, China.

SARM1 is a key executioner of axonal degeneration, acting through NAD⁺ depletion by NADase activity of its TIR domain. Although normally autoinhibited, SARM1 becomes activated in response to axonal damage; however, the underlying mechanism remains unclear. Here, using a class of pyridine-containing compounds that trigger SARM1-dependent axon degeneration, we uncover a two-step activation process.

View Article and Find Full Text PDF